XTX Topco’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$770K Sell
315,743
-160,564
-34% -$322K 0.01% 1643
2025
Q4
$653K Sell
476,307
-297,896
-38% -$393K 0.02% 1375
2025
Q3
$960K Buy
774,203
+746,431
+2,688% +$890K 0.05% 598
2025
Q2
$31.4K Buy
27,772
+7,026
+34% +$9.34K ﹤0.01% 2098
2025
Q1
$30.3K Sell
20,746
-137,791
-87% -$260K ﹤0.01% 2078
2024
Q4
$338K Buy
+158,537
New +$391K 0.03% 1116
2024
Q2
Sell
-35,765
Closed -$160K 1822
2024
Q1
$160K Buy
35,765
+379
+1% +$1.58K 0.02% 1245
2023
Q4
$114K Sell
35,386
-38,604
-52% -$109K 0.02% 1102
2023
Q3
$235K Buy
73,990
+28,159
+61% +$123K 0.04% 916
2023
Q2
$228K Buy
45,831
+259
+0.6% +$1.4K 0.04% 923
2023
Q1
$225K Sell
45,572
-71,264
-61% -$457K 0.05% 865
2022
Q4
$735K Buy
116,836
+78,194
+202% +$724K 0.16% 158
2022
Q3
$417K Buy
+38,642
New +$525K 0.1% 319

Other funds holding ALLO